Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol.
about
Pharmacological interventions for the acute management of hyperkalaemia in adultsTreatment for periodic paralysisHypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteersBeta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscleTargeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness.Hyperkalemia.Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.Na+,K+-pump stimulation improves contractility in isolated muscles of mice with hyperkalemic periodic paralysisTreatment of hyperkalaemia with intravenous salbutamol.Understanding the physiology of the asymptomatic diaphragm of the M1592V hyperkalemic periodic paralysis mouse.Effect of norepinephrine on swelling-induced potassium transport in duck red cells. Evidence against a volume-regulatory decrease under physiological conditions.Physiological basis for muscle stiffness and weakness in a knock-in M1592V mouse model of hyperkalemic periodic paralysisDifferential diagnosis of hyperkalemia: an update to a complex problem.Quantification of Na+,K+ pumps and their transport rate in skeletal muscle: functional significanceThe role of skeletal muscle beta-adrenoreceptors in the regulation of plasma potassium.Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients.Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use.Adynamia episodica hereditaria. Treatment with salbutamol.The Na+,K+ pump and muscle excitability.Salbutamol: beware of the paradox!The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men.Effect of propranolol on total exchangeable body potassium and total exchangeable body sodium in essential hypertension.Review of the Diagnosis and Treatment of Periodic Paralysis.Inherited muscle and brain channelopathies.Adynamia episodica hereditaria: what causes the weakness?
P2860
Q24186355-EF423706-63F8-4349-B288-A6D000BC3215Q24242271-3167E822-4A05-4B5B-A922-C94F11151A36Q28359806-9389BF76-2515-420C-8A42-F2F24ACECD07Q28571404-6E06C8A5-B07A-43DE-86C3-C86E0D22D698Q30481379-EC946BEB-38E2-4B75-8892-48EDEB376BA7Q33581352-E0EADBFA-57BA-44BB-8B5F-4989CB474762Q34416215-435DAEBA-A593-4176-889F-738507DFD8F1Q34518673-1B36F146-2ECA-43AC-8869-06E1D5C59EBEQ35102151-AD27C001-B3F2-458D-B7D9-0D26FCDE2904Q35626591-05A7ADC9-8940-4586-A222-E56A0C0A79E0Q36333205-2EE0D2A0-41FA-4D9E-9787-3227D92E488CQ36409420-5A0F4B0C-42F0-4D67-B937-455BDBB01B89Q36597849-FB78C6C5-08D4-4C20-9A5A-C46E522353AFQ37082990-ADF21A44-3CE3-4DCA-8FEA-A1F38A8ED075Q37209186-CEB7306F-065F-4415-BE16-53AC0AB46DCFQ39139796-A4B21F9D-7A0A-4116-A3C7-FC45FD4C6D71Q40149996-84B05FC1-5973-4BBF-8DA9-86B56F8B79DBQ40260203-8EB34380-BF39-4496-A297-69ECF5FD345CQ41429738-B1D3ECA8-C377-49B7-BA58-F794731F6E25Q41717098-348B1A4C-DE3D-4747-8D23-7FEB0250DF43Q41760126-A1EC48CB-FABF-481F-9B55-358A8575C77DQ41932497-95D1DB6A-B206-4476-B383-07725C920385Q42532104-CDE02993-DFB8-4262-93EB-05321FB536DBQ45233404-04CFCDE3-27EA-4B70-B24D-17D97BB3B33DQ45957826-8F196045-11B8-4086-90E3-6F14586354C1Q48725401-3131341C-7502-4D2B-972D-E0530E45C156Q51747190-97260EAF-39B9-4276-AF5C-24387DC4397A
P2860
Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Treatment of attacks in hyperk ...... s by inhalation of salbutamol.
@en
Treatment of attacks in hyperk ...... s by inhalation of salbutamol.
@nl
type
label
Treatment of attacks in hyperk ...... s by inhalation of salbutamol.
@en
Treatment of attacks in hyperk ...... s by inhalation of salbutamol.
@nl
prefLabel
Treatment of attacks in hyperk ...... s by inhalation of salbutamol.
@en
Treatment of attacks in hyperk ...... s by inhalation of salbutamol.
@nl
P1433
P1476
Treatment of attacks in hyperk ...... s by inhalation of salbutamol.
@en
P2093
P304
P356
10.1016/S0140-6736(76)91340-4
P407
P577
1976-01-01T00:00:00Z